Asthma Therapeutics Market
- 2026 年市場規模
- USD 20.44 Bn
- 2033 年預估規模
- USD 23.30 Bn
- 年複合成長率 CAGR
- 1.9%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Asthma Therapeutics Market, By Drug Class (Corticosteroids, Beta2-Agonists (Long-acting and Short-acting), Leukotriene Inhibitors, Long-acting Muscarinic Antagonists (LAMA), Interleukin Antagonists, Anti-immunoglobulin E (IgE) Agents, Combination Products (Including Beta2 Agonists/Corticosteroids, Beta2 Agonists/Muscarinic Antagonists/Corticosteroids, and Others), and Others), By Route of Administration (Oral, Inhalation, and Injection), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
Asthma is a long-term inflammatory disease that causes inflammation and narrowing of the airways in the lung. It is characterized by various symptoms such as swelling or inflammation in the airways linings, coughing, shortness of breath, and tightness of chest. Asthma is classified into many different types including allergic asthma, non-allergic asthma, adult onset asthma, exercised induced asthma (that occurs with physical exertion), nocturnal asthma, and occupational asthma. Nocturnal is also known as the nighttime asthma. It is very serious type of asthma therefore, it needs a proper diagnosis and treatment.
Market Dynamics
Increasing launches of nebulizer by key players is expected to propel global asthma therapeutics market growth. For instance, in October 2018, Koninklijke Philips N.V. announced launch of its new mesh nebulizer, InnoSpire Go, in North America. This is used for the treatment of respiratory diseases including asthma. It is portable, hand-held nebulizer system, which is short time treatment. It delivers the medicine in just four minutes. InnoSpire Go designed for both adults and children.
However, product recall is major restraining factor for asthma therapeutics market growth, which is expected to hamper the market growth. For instance, in August 2018, Camber Pharmaceuticals were issued product recall alert from U.S. Food and Drug Administration for its Montelukast Sodium Tablets. These tablets are recalled because Montelukast Sodium Tablet bottles contain wrong medicine (Losartan Potassium Tablet).
Key features of the study
• This report provides in-depth analysis of the global asthma therapeutics market size (USD Bn), and compound annual growth rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025, as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global asthma therapeutics market based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, GlaxoSmithKline Plc., Philips Healthcare, AstraZeneca Plc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, Sanofi-Aventis SA, CareFusion Corporation, Sunovion Pharmaceuticals, Inc. Merck & Co., Inc., and Roche Diagnostics.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global asthma therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for global asthma therapeutics market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• Drug Class Insights (Revenue, USD Bn, 2026 - 2033)
o Corticosteroids
o Beta2-Agonists (Long-Acting and Short-Acting)
o Leukotriene Inhibitors
o Long-Acting Muscarinic Antagonists (LAMA)
o Interleukin Antagonists
o Anti-Immunoglobulin E (IgE) Agents
o Combination Products
o Others
• Route of Administration Insights (Revenue, USD Bn, 2026 - 2033)
o Oral, Inhalation
o Injection
• Distribution Channel Insights (Revenue, USD Bn, 2026 - 2033)
o Hospitals Pharmacies
o Retail Pharmacies
o Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o GlaxoSmithKline Plc.
o Philips Healthcare
o AstraZeneca Plc.
o Teva Pharmaceutical Industries Ltd.
o Boehringer Ingelheim GmbH,
o Sanofi-Aventis SA
o CareFusion Corporation
o Sunovion Pharmaceuticals, Inc.
o Merck & Co., Inc.
o Roche Diagnostics
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Class
Market Snippet, By Route of Administration
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technology Advancements
o Epidemiology
o Product Recalls
o Government Initiatives
o Historical Overview
o Merger and Acquisition
o Regulatory and Reimbursement Scenario
o PORTER’S Five Forces
o PEST Analysis
4. Global Asthma Therapeutics Market, By Drug Class, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Corticosteroids
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Beta2-Agonists (Long-Acting and Short-Acting)
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Leukotriene Inhibitors
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Long-Acting Muscarinic Antagonists (LAMA)
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Interleukin Antagonists
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Anti-Immunoglobulin E (IgE) Agents
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Combination Products
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Others
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
5. Global Asthma Therapeutics Market, By Route of Administration, 2026-2033, (USD Bn)
o Oral
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Inhalation
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Injection
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
6. Global Asthma Therapeutics Market, By Distribution Chanel, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Hospitals Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Retail Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Online Pharmacies
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
7. Global Asthma Therapeutics Market, By Region, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
o US.
o Canada
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
o UK.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By Drug Class, 2026-2033, (USD Bn)
Market Size and Forecast, By Route of Administration, 2026-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Bn)
Market Size and Forecast By Country, 2026-2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
GlaxoSmithKline Plc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Philips Healthcare
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
AstraZeneca Plc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Boehringer Ingelheim GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sanofi- Aventis SA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
CareFusion Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sunovion Pharmaceutical Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Merck & Co. Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Roche Diagnostics
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們